Company intelligence / Profile preview

Morningside Venture Capital

Newton, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Morningside Venture Investments is a family office that has been investing in early-stage life sciences, biotechnology, and digital health companies since 1986. They focus on long-term company-building and ethical investing, with a portfolio including firms like Stealth BioTherapeutics, Kezar Life Sciences, and Apellis Pharmaceuticals. They have made over 190 investments with 30+ exits, pioneering work in areas like oncolytic viral therapy and mitochondrial medicine.

Industry: Investors

Beyond the preview

Go deeper on Morningside Venture Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Morningside Venture Capital.

Explore the full profile